ECSS
TMDX icon

Eurizon Capital SGR SpA’s Transmedics TMDX Stock Holding History

Eurizon Capital SGR SpA’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.1K Hold
655
– – ﹤0.01% 1051
2026
Q1 		$62.1K Hold
655
– – ﹤0.01% 987
2025
Q4 		$79.8K Buy
+655
New +$82.2K ﹤0.01% 839

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Eurizon Capital SGR SpA's TMDX Position: Q2 2026 in Review

Eurizon Capital SGR SpA held its Transmedics (TMDX) position steady in Q2 2026 at 655 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Eurizon Capital SGR SpA first reported a position in TMDX in Q4 2025 and has held it in 3 quarters since. The position peaked at $79.8K in Q4 2025. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Eurizon Capital SGR SpA held 655 shares of Transmedics worth $44.1K as of Q2 2026.
  • Eurizon Capital SGR SpA left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #1051 holding.
  • Eurizon Capital SGR SpA first reported a position in Transmedics in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Transmedics position peaked at $79.8K in Q4 2025.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.